Impact of Extending Beta-Lactam Infusions on IV Access Requirements

Impact of Extending Beta-Lactam Infusions on IV Access Requirements

This study aimed to determine if extended infusion (EI; over > 3 hr) beta-lactam therapy increased IV access requirements compared with traditional dosing (TD; over 30 min). Eighty-six adult ICU patients treated with TD anti-pseudomonal beta-lactams who underwent therapeutic drug monitoring (TDM)...

Full description

Saved in:
Bibliographic Details
Main Authors: Kirstin J. Kooda, PharmD, Julia Nelson, BS, Sara E. Ausman, PharmD, Christina G. Rivera, PharmD, Omar M. Abu Saleh, MBBS, Andrew D. Rule, MD, Ryan W. Stevens, PharmD, Micaela N. Warfield, PharmD, Yanjun Zhao, PharmD, Erin F. Barreto, PharmD, PhD, on behalf of the Beta Lactam Optimization and Outcomes Management (BLOOM) Study Group, Laura M. Dinnes, PharmD, Ognjen Gajic, MD, Laurie A. Meade, RN, Rebecca J. Wessel, DPT, MBA.
Format: Article
Language:English
Published: Wolters Kluwer 2025-08-01
Series:Critical Care Explorations
Online Access:http://journals.lww.com/10.1097/CCE.0000000000001299
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items